科研
教育
解决方案
登录
CN
EN - English
CN - 中文
DE - Deutsch
ES - Español
KR - 한국어
IT - Italiano
FR - Français
PT - Português
TR - Turkish
JA - Japanese
Department of Genitourinary Medical Oncology Research,
Division of Cancer Medicine,
Department of Genitourinary Medical Oncology Research, Division of Cancer Medicine
Peter Shepherd has not added Biography.
If you are Peter Shepherd and would like to personalize this page please email our Author Liaison for assistance.
Genome-wide CRISPR screens reveal synthetic lethality of RNASEH2 deficiency and ATR inhibition.
Oncogene 04, 2019 | Pubmed ID: 30532030
The estrogen receptor variants β2 and β5 induce stem cell characteristics and chemotherapy resistance in prostate cancer through activation of hypoxic signaling.
Oncotarget Nov, 2018 | Pubmed ID: 30555629
The MD Anderson Prostate Cancer Patient-derived Xenograft Series (MDA PCa PDX) Captures the Molecular Landscape of Prostate Cancer and Facilitates Marker-driven Therapy Development.
Clinical cancer research : an official journal of the American Association for Cancer Research Sep, 2020 | Pubmed ID: 32576626
The University of Texas MD Anderson Cancer Center
Lindsey K. Sablatura1,
Kristin M. Bircsak2,
Peter Shepherd3,
Karla Queiroz4,
Mary C. Farach-Carson1,5,6,
Pamela E. Constantinou1,7,
Anthony Saleh2,
Nora Navone3,
Daniel A. Harrington1,5,6
1Department of BioSciences, Rice University,
2, Mimetas US Inc,
3Department of Genitourinary Medical Oncology Research, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center,
4, Mimetas B.V.,
5Department of Bioengineering, Rice University,
6Department of Diagnostic and Biomedical Sciences, The University of Texas Health Science Center,
7Sheikh Ahmed Center for Pancreatic Cancer Research, The University of Texas MD Anderson Cancer Center
政策
使用条款
隐私
联系我们
向图书馆推荐
JoVE 新闻简报
JoVE Journal
技术专题合集
JoVE Encyclopedia of Experiments
档案
JoVE Core
JoVE Business
JoVE Science Education
JoVE Lab Manual
教师资源中心
发表
图书馆员
访问权限
关于 JoVE
版权所属 © 2024 MyJoVE 公司版权所有,本公司不涉及任何医疗业务和医疗服务。